grant

Small Molecular Inactivators of HIV

NIHUS FederalResearch GrantFY2025AIDSAIDS VirusAcetyl CoAAcetyl Coenzyme AAcquired Immune DeficiencyAcquired Immune Deficiency SyndromeAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency SyndromeAcquired Immunodeficiency Syndrome VirusBiological TestingClinicalCollaborationsDeath RateDiseaseDisorderDrug KineticsDrug PrecursorsDrug resistanceDrugsFDA approvedFemaleFormulationGenerationsHIVHIV InfectionsHIV resistanceHIV resistantHIV-1HIV-IHIV1HTLV-III InfectionsHTLV-III-LAV InfectionsHumanHuman Immunodeficiency Virus Type 1Human Immunodeficiency VirusesHuman T-Lymphotropic Virus Type III InfectionsHuman immunodeficiency virus 1InjectableIntermediary MetabolismL-LysineLAV-HTLV-IIILeadLymphadenopathy-Associated VirusLysineMedicationMetabolic ProcessesMetabolismModern ManMolecularPBMCPb elementPeripheral Blood Mononuclear CellPharmaceutical PreparationsPharmacokineticsPositionPositioning AttributePro-DrugsProcessProdrugsProteinsResistance developmentResistant developmentS-acetate Coenzyme AToxic effectToxicitiesTranslatingTransmissionVaccinesVariantVariationViralViral ActivityViral FunctionViral PhysiologyVirusVirus ReplicationVirus-HIVWorkchemical synthesisdeveloping resistancedrug resistantdrug/agentheavy metal Pbheavy metal leadin vivomalemicrobicidalmicrobicidemortality ratemortality ratiopre-clinical toxicitypreclinical toxicitypreventpreventingresistance strainresistance to Drugresistant strainresistant to Drugscaffoldscaffoldingtransacylationtransmission processviral multiplicationviral replicationvirus multiplication
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

We have developed and studied our molecule both in the active form and as a prodrug. We have developed large-scale syntheses for these molecules and worked in collaboration to study their antiviral activity and evaluate their preclinical toxicity. Overall, the molecules show broad range of activity across a panel of HIV-1 clinical isolates in…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →